|
⚲
|
| Keyboard |
| Schnell David
✚
|
|
|---|---|
| CIK # | 0001162060 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001162060] | |
| 4 | [0001162060] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2020-05-20 | Grant | 16,806 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Stock Option (Right to Buy) · derivative
|
2019-05-15 | Grant | 24,000 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Series B Preferred Stock · derivative
|
2019-04-08 | Conversion | 1,300,000 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Series D Preferred Stock · derivative
|
2019-04-08 | Conversion | 100,000 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Series C Preferred Stock · derivative
|
2019-04-08 | Conversion | 525,000 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Series A Preferred Stock · derivative
|
2019-04-08 | Conversion | 3,000,000 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2019-04-08 | Conversion | 4,925,000 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2015-03-24 | Other | 900,383 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2015-03-24 | Other | 20,357 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2015-03-24 | Other | 20,357 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Buy | 671,807 | $8.00 | 5,374,456 |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 261,977 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 261,977 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 76,949 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 1,530,269 | ||
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2014-09-29 | Conversion | 102,301 | ||
|
Vitae Pharmaceuticals Inc VTAE
Series A-2 Preferred Stock · derivative
|
2014-09-29 | Conversion | 173,912 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series A-2 Preferred Stock · derivative
|
2014-09-29 | Conversion | 173,912 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series B Preferred Stock · derivative
|
2014-09-29 | Conversion | 102,301 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Series B Preferred Stock · derivative
|
2014-09-29 | Conversion | 1,530,269 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||